| Biological insights from 108 schizophrenia-associated genetic loci C Pantelis, GN Papadimitriou, S Papiol, E Parkhomenko, MT Pato, ... Nature 511 (7510), 421-427, 2014 | 5446 | 2014 |
| Biological insights from 108 schizophrenia-associated genetic loci S Ripke, BM Neale, A Corvin, JTR Walters, KH Farh, PA Holmans, P Lee, ... Nature 511 (7510), 421, 2014 | 2492 | 2014 |
| Modeling linkage disequilibrium increases accuracy of polygenic risk scores BJ Vilhjálmsson, J Yang, HK Finucane, A Gusev, S Lindström, S Ripke, ... The american journal of human genetics 97 (4), 576-592, 2015 | 1423 | 2015 |
| White matter changes in schizophrenia: evidence for myelin-related dysfunction KL Davis, DG Stewart, JI Friedman, M Buchsbaum, PD Harvey, PR Hof, ... Archives of general psychiatry 60 (5), 443-456, 2003 | 1015 | 2003 |
| Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects CR Marshall, DP Howrigan, D Merico, B Thiruvahindrapuram, W Wu, ... Nature genetics 49 (1), 27-35, 2017 | 981 | 2017 |
| Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases A Gusev, SH Lee, G Trynka, H Finucane, BJ Vilhjálmsson, H Xu, C Zang, ... The American Journal of Human Genetics 95 (5), 535-552, 2014 | 673 | 2014 |
| Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes DM Ruderfer, S Ripke, A McQuillin, J Boocock, EA Stahl, JMW Pavlides, ... Cell 173 (7), 1705-1715. e16, 2018 | 555 | 2018 |
| CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy JI Friedman, T Vrijenhoek, S Markx, IM Janssen, WA Van Der Vliet, ... Molecular psychiatry 13 (3), 261-266, 2008 | 373 | 2008 |
| Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer’s disease and normal aging JI Friedman, PD Harvey, T Coleman, PJ Moriarty, C Bowie, M Parrella, ... American Journal of Psychiatry 158 (9), 1441-1448, 2001 | 332 | 2001 |
| Strong synaptic transmission impact by copy number variations in schizophrenia JT Glessner, MP Reilly, CE Kim, N Takahashi, A Albano, C Hou, ... Proceedings of the National Academy of Sciences 107 (23), 10584-10589, 2010 | 274 | 2010 |
| Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients JI Friedman, C Tang, D Carpenter, M Buchsbaum, J Schmeidler, ... American Journal of Psychiatry 165 (8), 1024-1032, 2008 | 269 | 2008 |
| Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists JI Friedman Psychopharmacology 174, 45-53, 2004 | 245 | 2004 |
| Pharmacologic strategies for augmenting cognitive performance in schizophrenia JI Friedman, H Temporini, KL Davis Biological psychiatry 45 (1), 1-16, 1999 | 238 | 1999 |
| The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease JI Friedman, DN Adler, KL Davis Biological psychiatry 46 (9), 1243-1252, 1999 | 225 | 1999 |
| A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia JI Friedman, DN Adler, E Howanitz, PD Harvey, G Brenner, H Temporini, ... Biological psychiatry 51 (5), 349-357, 2002 | 217 | 2002 |
| A comparison of ten polygenic score methods for psychiatric disorders applied across multiple cohorts G Ni, J Zeng, JA Revez, Y Wang, Z Zheng, T Ge, R Restuadi, J Kiewa, ... Biological psychiatry 90 (9), 611-620, 2021 | 163 | 2021 |
| Estimation of genetic correlation via linkage disequilibrium score regression and genomic restricted maximum likelihood G Ni, G Moser, S Ripke, BM Neale, A Corvin, JTR Walters, KH Farh, ... The American Journal of Human Genetics 102 (6), 1185-1194, 2018 | 162 | 2018 |
| Diffusion tensor imaging in schizophrenia MS Buchsbaum, J Friedman, BR Buchsbaum, KW Chu, EA Hazlett, ... Biological psychiatry 60 (11), 1181-1187, 2006 | 159 | 2006 |
| Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients JI Friedman, CY Tang, HJ de Haas, L Changchien, G Goliasch, P Dabas, ... JACC: cardiovascular imaging 7 (10), 1039-1053, 2014 | 140 | 2014 |
| Guanfacine treatment of cognitive impairment in schizophrenia JI Friedman, DN Adler, HD Temporini, E Kemether, PD Harvey, L White, ... Neuropsychopharmacology 25 (3), 402-409, 2001 | 131 | 2001 |
